TipRanks
M1 Kliniken AG (DE:M12)
XETRA:M12
Germany Market
M12
M1 Kliniken AG
RESEARCH TOOLSreports
Want to see DE:M12 full AI Analyst Report?

M1 Kliniken AG (M12) Ratios

13 Followers

M1 Kliniken AG Ratios

DE:M12's free cash flow for Q2 2026 was €0.31. For the 2026 fiscal year, DE:M12's free cash flow was decreased by € and operating cash flow was €0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.48 2.82 1.91 1.90 2.86
Quick Ratio
 4.90 1.82 1.08 1.12 2.13
Cash Ratio
 3.12 1.19 0.49 0.38 0.94
Solvency Ratio
 0.98 0.69 0.40 0.22 0.19
Operating Cash Flow Ratio
 1.20 1.20 0.70 0.13 0.56
Short-Term Operating Cash Flow Coverage
 7.38 7.29 2.85 2.22 8.84
Net Current Asset Value
€ 80.95M€ 50.06M€ 29.90M€ 40.86M€ 53.33M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.05 0.06 0.08 0.10
Debt-to-Equity Ratio
 0.05 0.09 0.10 0.15 0.21
Debt-to-Capital Ratio
 0.05 0.08 0.09 0.13 0.17
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.02 0.03
Financial Leverage Ratio
 1.43 1.58 1.77 1.88 2.06
Debt Service Coverage Ratio
 6.38 4.52 1.97 3.49 4.02
Interest Coverage Ratio
 33.28 23.87 13.89 11.65 11.29
Debt to Market Cap
 <0.01 0.01 0.03 0.03 0.03
Interest Debt Per Share
 0.37 0.64 0.67 0.96 1.12
Net Debt to EBITDA
 -1.49 -0.68 -0.33 -0.24 -0.96
Profitability Margins
Gross Profit Margin
18.52%13.02%18.75%10.27%7.61%
EBIT Margin
12.53%9.77%8.32%5.21%3.58%
EBITDA Margin
14.24%11.11%9.86%6.89%5.63%
Operating Profit Margin
12.53%10.09%7.89%4.96%3.28%
Pretax Profit Margin
12.90%9.35%7.75%5.20%3.59%
Net Profit Margin
7.86%6.08%4.72%3.25%1.51%
Continuous Operations Profit Margin
8.89%6.62%5.25%3.69%2.48%
Net Income Per EBT
60.96%64.98%60.91%62.47%42.19%
EBT Per EBIT
102.96%92.71%98.30%104.75%109.48%
Return on Assets (ROA)
11.40%11.69%8.53%4.82%2.19%
Return on Equity (ROE)
16.58%18.45%15.10%9.07%4.52%
Return on Capital Employed (ROCE)
20.40%23.31%18.56%10.15%5.86%
Return on Invested Capital (ROIC)
13.79%15.76%11.46%6.91%3.91%
Return on Tangible Assets
18.04%22.33%15.95%8.18%4.21%
Earnings Yield
5.31%6.28%5.20%4.80%2.60%
Efficiency Ratios
Receivables Turnover
 98.63 41.71 19.25 11.29 12.66
Payables Turnover
 115.16 37.56 21.25 8.54 13.71
Inventory Turnover
 18.67 9.98 7.63 6.23 9.55
Fixed Asset Turnover
 44.28 38.70 26.27 22.93 16.61
Asset Turnover
 1.45 1.92 1.81 1.49 1.45
Working Capital Turnover Ratio
 3.56 7.48 7.36 5.18 4.18
Cash Conversion Cycle
 20.08 35.62 49.64 48.11 40.41
Days of Sales Outstanding
 3.70 8.75 18.96 32.33 28.82
Days of Inventory Outstanding
 19.55 36.59 47.86 58.54 38.20
Days of Payables Outstanding
 3.17 9.72 17.18 42.76 26.62
Operating Cycle
 23.25 45.34 66.82 90.88 67.03
Cash Flow Ratios
Operating Cash Flow Per Share
 1.25 2.05 1.65 0.41 1.15
Free Cash Flow Per Share
 1.23 2.04 1.59 0.36 1.05
CapEx Per Share
 0.01 <0.01 0.05 0.05 0.10
Free Cash Flow to Operating Cash Flow
 0.99 1.00 0.97 0.87 0.92
Dividend Paid and CapEx Coverage Ratio
 2.45 4.03 2.96 2.61 5.85
Capital Expenditure Coverage Ratio
 109.30 344.29 30.69 7.74 11.86
Operating Cash Flow Coverage Ratio
 3.94 3.70 2.93 0.46 1.07
Operating Cash Flow to Sales Ratio
 0.09 0.10 0.09 0.02 0.07
Free Cash Flow Yield
6.02%10.73%9.59%3.17%11.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.72 15.97 19.30 20.85 38.43
Price-to-Sales (P/S) Ratio
 1.49 0.97 0.91 0.68 0.58
Price-to-Book (P/B) Ratio
 3.07 2.94 2.90 1.89 1.74
Price-to-Free Cash Flow (P/FCF) Ratio
 16.60 9.32 10.42 31.50 8.62
Price-to-Operating Cash Flow Ratio
 16.37 9.29 10.08 27.43 7.89
Price-to-Earnings Growth (PEG) Ratio
 1.38 0.42 0.33 0.17 -0.77
Price-to-Fair Value
 3.07 2.94 2.90 1.89 1.74
Enterprise Value Multiple
 8.96 8.03 8.88 9.58 9.36
Enterprise Value
 328.48M 325.04M 297.00M 208.87M 150.46M
EV to EBITDA
 8.96 8.03 8.88 9.58 9.36
EV to Sales
 1.28 0.89 0.88 0.66 0.53
EV to Free Cash Flow
 14.23 8.59 10.05 30.72 7.82
EV to Operating Cash Flow
 14.10 8.57 9.72 26.75 7.16
Tangible Book Value Per Share
 4.65 3.22 2.52 2.92 2.65
Shareholders’ Equity Per Share
 6.64 6.46 5.72 5.92 5.22
Tax and Other Ratios
Effective Tax Rate
 0.31 0.29 0.32 0.29 0.31
Revenue Per Share
 13.77 19.63 18.28 16.54 15.58
Net Income Per Share
 1.08 1.19 0.86 0.54 0.24
Tax Burden
 0.61 0.65 0.61 0.62 0.42
Interest Burden
 1.03 0.96 0.93 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.07 0.02 0.02 <0.01 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.15 1.57 1.72 0.76 4.87
Currency in EUR